Progression in acute stroke: Value of the initial NIH stroke scale score on patient stratification in future trials

Stroke

Volumn 30, Issue 6, 1999, Pages 1208-1212

  DeGraba, Thomas J ^b   Hallenbeck, John M ^c   Pettigrew, Karen D ^c   Dutka, Andrew J ^c   Kelly, Brian J ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Clinical Stroke Research Unit   (United States)

^c NONE

Author keywords

Outcome; Stroke assessment; Stroke, acute

Indexed keywords

ACUTE DISEASE; AGED; ARTICLE; BAYES THEOREM; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0033031230     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.6.1208     Document Type: Article

References (24)

1. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, and the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
2. The RANTTAS Investigators. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). Stroke. 1996;27:1453-1458.
3. Major Ongoing Stroke Trials. European and Australian Cooperative Stroke Study II (ECASS-II). Stroke. 1998;29:551. .
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
5. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, Faught RE Jr, Haley EC Jr, for the RANTTAS Investigators. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. Stroke. 1998;29:447-453.
6. Davalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40: 1865-1869.
7. Toni D, Fiorelli M, Bastianello S, Falcou A, Sette G, Ceschin V, Sacchetti ML, Argentino C. Acute ischemic strokes improving during the first 48 hours of onset: predictability, outcome, and possible mechanisms. Stroke. 1997;22:10-14.
8. Loyke HF. The three phases of blood pressure in stroke. South Med J. 1990;83:660-663.
9. Choi D. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci. 1990;10:2493-2501.
10. Kuroda S, Siesjö BK. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci. 1997;4:199-212.
11. Chalmers-Redman RME, Fraser AD, Ju WYH, Wadia J, Tatton NA, Tatton WG. Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischemia. Int Rev Neurobiol. 1997:1-25.
12. Hallenbeck JM. Inflammatory reactions at the blood-endothelial interface in acute stroke. Adv Neurol. 1996;281-300.
13. DeGraba TJ. The role of inflammation following acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology. 1998;51(suppl 3):S62-S68.
14. Bjork J, Hedqvist P, Arfors KE. Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation. 1982;6:189-200.
15. Goldstein LB, Bertels C, PA-C, Davis JN. Interrater reliability of the NIH Stroke Scale. Arch Neurol. 1989;46:660-662.
16. Rao CR. Linear Statistical Inference and Its Applications. New York, NY: John Wiley & Sons; 1965: 413-419, 487-493.
17. Biller J, Love BB, Marsh EE, Jones MP, Knepper LE, Jiang D, Adams HP, Gordon DL. Spontaneous improvement after acute ischemic stroke. Stroke. 1990;21:1008-1012.
18. Toni D, Fiorelli M, Zanette EM, Sacchetti ML, Salerno A, Argentino C, Solaro M, Fieschi C. Early spontaneous improvement and deterioration of ischemic stroke patients. Stroke. 1998;29:1144-1148.
19. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilla C, Fieschi C. Progressing neurological deficit secondary to acute ischemic stroke. Arch Neurol. 1995;52:670-675.
20. Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke. 1994;25:362-365.
21. Fiorelli M, Alperovitch A, Argentino C, Sacchetti ML, Toni D, Sette G, Cavalleti C, Gori C, Fieschi C, for the Italian Acute Stroke Study Group. Prediction of long-term outcome in the early hours following acute ischemic stroke. Arch Neurol. 1995;52:250-255.
22. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subacute heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
23. Jones HR, Millikan CH. Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke. 1976;7:64-71.
24. Jones HR Jr, Millikan CH, Sandok BA. Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke. 1980;11: 173-177.